Trinity Biotech
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-09-30 |
|---|---|---|
Revenue | $11,063 | $14,247 |
Gross Profit | 3,546 | 6,086 |
EBITDA | -2,214 | 120 |
EBIT | -2,942 | -536 |
Net Income | -17,463 | -5,111 |
Net Change In Cash | 11,063 | 14,247 |
Free Cash Flow | -1,540 | -77 |
Cash | 5,138 | 1,341 |
Basic Shares | 620 | 621 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $43,785 | $61,555 | $56,832 | $62,521 |
Gross Profit | 16,887 | 21,441 | 19,450 | 22,048 |
EBITDA | -21,379 | -16,905 | -24,098 | -16,713 |
EBIT | -24,063 | -18,770 | -25,874 | -19,046 |
Net Income | -37,376 | -31,789 | -24,018 | -41,002 |
Net Change In Cash | 43,785 | 61,555 | 56,832 | 62,521 |
Free Cash Flow | -12,152 | -14,255 | -12,360 | -6,898 |
Cash | 5,138 | 5,167 | 3,691 | 6,578 |
Basic Shares | 619 | 598 | 255 | 259 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.40 |
2025-06-30 | -$14.40 |
2025-03-31 | -$1.24 |
2024-12-31 | -$26.34 |